Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease

Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neur...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 25; no. 11; p. 2502
Main Authors Ostendorf, Friederike, Metzdorf, Judith, Gold, Ralf, Haghikia, Aiden, Tönges, Lars
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 28.05.2020
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neurodegenerative diseases including dopaminergic neurons in Parkinson´s disease. In this study, we employed a model system for PD of cultured primary mesencephalic cells and used the pesticide rotenone to model dopaminergic cell damage. We examined neuroprotective effects of the Rho kinase inhibitor Fasudil and the short chain fatty acid (SCFA) propionic acid on primary neurons in cell morphological assays, cell survival, gene and protein expression. Fasudil application resulted in significantly enhanced neuritic outgrowth and increased cell survival of dopaminergic cells. The application of propionic acid primarily promoted cell survival of dopaminergic cells against rotenone toxicity and increased neurite outgrowth to a moderate extent. Interestingly, Fasudil augmented gene expression of synaptophysin whereas gene expression levels of tyrosine hydroxylase (TH) were substantially increased by propionic acid. Concerning protein expression propionic acid treatment increased STAT3 levels but did not lead to an increased phosphorylation indicative of pathway activation. Our findings indicate that both Fasudil and propionic acid treatment show beneficial potential in rotenone-lesioned primary mesencephalic cells.
AbstractList Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neurodegenerative diseases including dopaminergic neurons in Parkinson´s disease. In this study, we employed a model system for PD of cultured primary mesencephalic cells and used the pesticide rotenone to model dopaminergic cell damage. We examined neuroprotective effects of the Rho kinase inhibitor Fasudil and the short chain fatty acid (SCFA) propionic acid on primary neurons in cell morphological assays, cell survival, gene and protein expression. Fasudil application resulted in significantly enhanced neuritic outgrowth and increased cell survival of dopaminergic cells. The application of propionic acid primarily promoted cell survival of dopaminergic cells against rotenone toxicity and increased neurite outgrowth to a moderate extent. Interestingly, Fasudil augmented gene expression of synaptophysin whereas gene expression levels of tyrosine hydroxylase (TH) were substantially increased by propionic acid. Concerning protein expression propionic acid treatment increased STAT3 levels but did not lead to an increased phosphorylation indicative of pathway activation. Our findings indicate that both Fasudil and propionic acid treatment show beneficial potential in rotenone-lesioned primary mesencephalic cells.
Author Ostendorf, Friederike
Gold, Ralf
Haghikia, Aiden
Metzdorf, Judith
Tönges, Lars
AuthorAffiliation 1 Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany; friederike.ostendorf@rub.de (F.O.); judith.metzdorf@rub.de (J.M.); ralf.gold@rub.de (R.G.); aiden.haghikia@rub.de (A.H.)
2 Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany
AuthorAffiliation_xml – name: 2 Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany
– name: 1 Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany; friederike.ostendorf@rub.de (F.O.); judith.metzdorf@rub.de (J.M.); ralf.gold@rub.de (R.G.); aiden.haghikia@rub.de (A.H.)
Author_xml – sequence: 1
  givenname: Friederike
  surname: Ostendorf
  fullname: Ostendorf, Friederike
  organization: Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany
– sequence: 2
  givenname: Judith
  surname: Metzdorf
  fullname: Metzdorf, Judith
  organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany
– sequence: 3
  givenname: Ralf
  surname: Gold
  fullname: Gold, Ralf
  organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany
– sequence: 4
  givenname: Aiden
  surname: Haghikia
  fullname: Haghikia, Aiden
  organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany
– sequence: 5
  givenname: Lars
  orcidid: 0000-0001-6621-144X
  surname: Tönges
  fullname: Tönges, Lars
  organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32481507$$D View this record in MEDLINE/PubMed
BookMark eNplkU1v1DAQhi3Uin7AD-CCfOO04LGdOL4grVoKK7WiQgvXaGJPFpfEXtlZRP89aReqVj2NNdbz-JXfE3YQUyTG3oB4r5QVH8Y0kNsNVGQFICshX7Bj0FIslND24NH5iJ2UciOEBA3VS3akpG6gEuaYjdc5bUOKwfGlC55j9PwCy86HgWPh60w4jRQnvtxgiGXi39JEdzH4Ov0JLky3PMSZ4qvIf4QpJ36VPA089fwa868ZSfFd4eehEBZ6xQ57HAq9_jdP2feLT-uzL4vLr59XZ8vLhdN1NS20NYCdQbCkGlNbX_e1xk70tbDCaWyM9b7Tjaor21srCaSF2qJoKtN5D-qUrfZen_Cm3eYwYr5tE4b2fpHypsU8BTdQSzVJazrnnCBNlhrfm0aCa1Ql5xxudn3cu7a7biTv5s_IODyRPr2J4We7Sb9boyQAqFkAe4HLqZRM_QMLor3rsX3W48y8ffzoA_G_OPUXKC2eRA
CitedBy_id crossref_primary_10_1016_j_trsl_2022_06_003
crossref_primary_10_3389_fnagi_2022_986127
crossref_primary_10_3934_bioeng_2021021
crossref_primary_10_4103_1673_5374_308089
crossref_primary_10_1002_mds_29803
crossref_primary_10_1016_j_heliyon_2024_e26377
crossref_primary_10_1007_s12035_024_04038_2
crossref_primary_10_1186_s12883_021_02544_7
crossref_primary_10_1080_10408398_2023_2272769
crossref_primary_10_3390_cells10040931
crossref_primary_10_1016_j_mce_2022_111572
crossref_primary_10_3390_ijms232012289
crossref_primary_10_1021_acsomega_3c04277
crossref_primary_10_1111_ene_15848
crossref_primary_10_1016_j_celrep_2024_113865
crossref_primary_10_1002_mds_29063
crossref_primary_10_1016_j_arr_2022_101759
crossref_primary_10_1186_s12929_022_00839_6
crossref_primary_10_1002_eng2_12858
crossref_primary_10_1016_j_ejphar_2022_174974
crossref_primary_10_1016_j_biopha_2021_111661
crossref_primary_10_1097_MD_0000000000037960
crossref_primary_10_1038_s41531_023_00554_5
crossref_primary_10_1007_s12264_023_01123_9
crossref_primary_10_1016_j_actbio_2021_03_071
crossref_primary_10_1093_brain_awab156
Cites_doi 10.3390/nu3100858
10.1111/jnc.14928
10.1016/j.stem.2018.06.015
10.1523/JNEUROSCI.0535-12.2012
10.1007/s12017-015-8374-6
10.1186/s40478-016-0310-y
10.1523/JNEUROSCI.23-34-10756.2003
10.1093/brain/aws254
10.1007/s12640-018-9931-1
10.1038/s41598-019-45348-z
10.1016/j.pharmthera.2015.11.012
10.3389/fneur.2019.01245
10.1002/mds.27304
10.5114/fn.2015.54426
10.1111/j.1600-079X.2007.00510.x
10.1186/s40168-018-0439-y
10.1016/j.cell.2016.11.018
10.1016/j.bbr.2006.07.025
10.1016/j.parkreldis.2016.08.019
10.1523/JNEUROSCI.20-09-03214.2000
10.1016/S0924-977X(99)00063-2
10.1016/j.neuropharm.2008.01.013
10.1074/jbc.M210432200
10.1016/j.jns.2015.03.022
10.1016/j.cell.2020.02.035
10.1126/science.6823561
10.1016/j.pharmthera.2018.03.008
10.1002/ana.20904
10.1523/JNEUROSCI.1359-19.2019
10.1097/00004836-200603000-00015
10.1371/journal.pone.0103740
10.1016/j.toxlet.2014.11.029
10.1111/j.1742-4658.2007.06004.x
10.1111/j.1365-2990.2007.00874.x
10.1111/j.1468-1331.2008.02056.x
10.1016/S0140-6736(14)61393-3
10.1038/s41582-020-0344-4
10.1002/mds.26605
10.3389/fendo.2020.00025
10.1523/JNEUROSCI.0096-06.2006
10.1016/j.neuint.2016.02.014
10.2165/00023210-200216100-00004
10.1371/journal.pone.0162696
10.1038/nrneurol.2015.197
10.1016/j.neuint.2018.10.015
10.1523/JNEUROSCI.22-20-08797.2002
10.1517/13543784.17.2.169
10.1101/cshperspect.a033118
10.1002/mds.28016
10.1002/mds.26069
10.1007/s12035-016-0249-9
10.1016/S0197-4580(02)00065-9
ContentType Journal Article
Copyright 2020 by the authors. 2020
Copyright_xml – notice: 2020 by the authors. 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOA
DOI 10.3390/molecules25112502
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE
CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_e6e297bccc0e4e9e8df7821c8352497c
10_3390_molecules25112502
32481507
Genre Journal Article
GroupedDBID ---
0R~
123
2WC
3V.
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
ABDBF
ABJCF
ABUWG
ACGFO
ACIWK
ACPRK
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
D1I
DIK
DU5
E3Z
EBD
ECM
EIF
EMOBN
ESTFP
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
HZ~
I09
KB.
KQ8
LK8
M1P
M7P
MODMG
M~E
NPM
O-U
O9-
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
SV3
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c465t-4971ab7a19e38769d6f64ab0f6090c4a879ddb483659f992e129169a0857bdd13
IEDL.DBID RPM
ISSN 1420-3049
IngestDate Tue Oct 22 14:49:24 EDT 2024
Tue Sep 17 20:39:15 EDT 2024
Fri Aug 23 04:59:02 EDT 2024
Tue Aug 27 13:46:47 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords neurodegeneration
rotenone
rho kinase
Parkinson’s disease
short chain fatty acids
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-4971ab7a19e38769d6f64ab0f6090c4a879ddb483659f992e129169a0857bdd13
ORCID 0000-0001-6621-144X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321113/
PMID 32481507
ParticipantIDs doaj_primary_oai_doaj_org_article_e6e297bccc0e4e9e8df7821c8352497c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7321113
crossref_primary_10_3390_molecules25112502
pubmed_primary_32481507
PublicationCentury 2000
PublicationDate 20200528
PublicationDateYYYYMMDD 2020-05-28
PublicationDate_xml – month: 5
  year: 2020
  text: 20200528
  day: 28
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2020
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Adler (ref_4) 2016; 31
Silva (ref_22) 2020; 11
(ref_40) 2015; 5
Unger (ref_11) 2016; 32
Jackson (ref_21) 2019; 10
Abdelli (ref_53) 2019; 9
Li (ref_26) 2002; 278
Hawkes (ref_8) 2007; 33
Radad (ref_28) 2015; 3
ref_52
Daihan (ref_14) 2015; 4
Kalia (ref_5) 2015; 386
Liu (ref_49) 2016; 54
Langston (ref_17) 1983; 219
Erkkinen (ref_1) 2017; 10
Cabin (ref_39) 2002; 22
Langston (ref_16) 2017; 7
Lin (ref_31) 2008; 44
Wong (ref_12) 2006; 40
Ghaisas (ref_13) 2015; 158
Leng (ref_37) 2006; 26
Vinolo (ref_51) 2011; 3
Frank (ref_25) 2012; 135
Sadler (ref_46) 2019; 40
Klingelhoefer (ref_2) 2015; 11
Perucca (ref_45) 2002; 16
Hahnen (ref_44) 2008; 17
Koch (ref_24) 2018; 189
Zhao (ref_29) 2015; 353
Sampson (ref_10) 2016; 167
Macfabe (ref_54) 2007; 176
Ascherio (ref_20) 2006; 60
Lei (ref_43) 2016; 95
ref_36
ref_33
ref_30
Srivastava (ref_32) 2007; 274
Sherer (ref_18) 2003; 23
Yuan (ref_19) 2015; 233
Bonnet (ref_23) 2000; 10
Duscha (ref_47) 2020; 180
Sommer (ref_50) 2018; 23
Poewe (ref_3) 2008; 15
Mulak (ref_9) 2018; 33
Scheperjans (ref_7) 2014; 30
Tatenhorst (ref_42) 2016; 4
Shultz (ref_55) 2008; 54
Mouhape (ref_27) 2018; 35
Braak (ref_6) 2003; 24
Scott (ref_41) 2012; 32
Hoyles (ref_15) 2018; 6
Trujillo (ref_34) 2018; 121
ref_48
Chen (ref_35) 2015; 17
Murphy (ref_38) 2000; 20
References_xml – volume: 3
  start-page: 858
  year: 2011
  ident: ref_51
  article-title: Regulation of Inflammation by Short Chain Fatty Acids
  publication-title: Nutrients
  doi: 10.3390/nu3100858
  contributor:
    fullname: Vinolo
– ident: ref_30
  doi: 10.1111/jnc.14928
– volume: 23
  start-page: 123
  year: 2018
  ident: ref_50
  article-title: Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson’s Disease
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2018.06.015
  contributor:
    fullname: Sommer
– volume: 32
  start-page: 10129
  year: 2012
  ident: ref_41
  article-title: α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0535-12.2012
  contributor:
    fullname: Scott
– volume: 17
  start-page: 454
  year: 2015
  ident: ref_35
  article-title: Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis
  publication-title: NeuroMol. Med.
  doi: 10.1007/s12017-015-8374-6
  contributor:
    fullname: Chen
– volume: 4
  start-page: 39
  year: 2016
  ident: ref_42
  article-title: Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-016-0310-y
  contributor:
    fullname: Tatenhorst
– volume: 23
  start-page: 10756
  year: 2003
  ident: ref_18
  article-title: Mechanism of Toxicity in Rotenone Models of Parkinson’s Disease
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-34-10756.2003
  contributor:
    fullname: Sherer
– volume: 135
  start-page: 3355
  year: 2012
  ident: ref_25
  article-title: Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
  publication-title: Brain
  doi: 10.1093/brain/aws254
  contributor:
    fullname: Frank
– volume: 35
  start-page: 71
  year: 2018
  ident: ref_27
  article-title: Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson’s Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism
  publication-title: Neurotox. Res.
  doi: 10.1007/s12640-018-9931-1
  contributor:
    fullname: Mouhape
– volume: 9
  start-page: 8824
  year: 2019
  ident: ref_53
  article-title: Propionic Acid Induces Gliosis and Neuro-inflammation through Modulation of PTEN/AKT Pathway in Autism Spectrum Disorder
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-45348-z
  contributor:
    fullname: Abdelli
– volume: 158
  start-page: 52
  year: 2015
  ident: ref_13
  article-title: Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2015.11.012
  contributor:
    fullname: Ghaisas
– volume: 10
  start-page: 1245
  year: 2019
  ident: ref_21
  article-title: Diet in Parkinson’s Disease: Critical Role for the Microbiome
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2019.01245
  contributor:
    fullname: Jackson
– volume: 33
  start-page: 398
  year: 2018
  ident: ref_9
  article-title: A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.27304
  contributor:
    fullname: Mulak
– volume: 3
  start-page: 250
  year: 2015
  ident: ref_28
  article-title: Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture
  publication-title: Folia Neuropathol.
  doi: 10.5114/fn.2015.54426
  contributor:
    fullname: Radad
– volume: 44
  start-page: 205
  year: 2008
  ident: ref_31
  article-title: Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats
  publication-title: J. Pineal Res.
  doi: 10.1111/j.1600-079X.2007.00510.x
  contributor:
    fullname: Lin
– volume: 6
  start-page: 55
  year: 2018
  ident: ref_15
  article-title: Microbiome-host systems interactions: Protective effects of propionate upon the blood–brain barrier
  publication-title: Microbiome
  doi: 10.1186/s40168-018-0439-y
  contributor:
    fullname: Hoyles
– volume: 7
  start-page: S11
  year: 2017
  ident: ref_16
  article-title: The MPTP Story
  publication-title: J. Park. Dis.
  contributor:
    fullname: Langston
– volume: 167
  start-page: 1469
  year: 2016
  ident: ref_10
  article-title: Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
  publication-title: Cell
  doi: 10.1016/j.cell.2016.11.018
  contributor:
    fullname: Sampson
– volume: 176
  start-page: 149
  year: 2007
  ident: ref_54
  article-title: Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2006.07.025
  contributor:
    fullname: Macfabe
– volume: 32
  start-page: 66
  year: 2016
  ident: ref_11
  article-title: Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
  publication-title: Park. Relat. Disord.
  doi: 10.1016/j.parkreldis.2016.08.019
  contributor:
    fullname: Unger
– volume: 20
  start-page: 3214
  year: 2000
  ident: ref_38
  article-title: Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.20-09-03214.2000
  contributor:
    fullname: Murphy
– volume: 10
  start-page: 97
  year: 2000
  ident: ref_23
  article-title: Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/S0924-977X(99)00063-2
  contributor:
    fullname: Bonnet
– volume: 54
  start-page: 901
  year: 2008
  ident: ref_55
  article-title: Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2008.01.013
  contributor:
    fullname: Shultz
– volume: 278
  start-page: 8516
  year: 2002
  ident: ref_26
  article-title: Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production
  publication-title: J. Boil. Chem.
  doi: 10.1074/jbc.M210432200
  contributor:
    fullname: Li
– volume: 353
  start-page: 28
  year: 2015
  ident: ref_29
  article-title: Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson’s disease
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2015.03.022
  contributor:
    fullname: Zhao
– volume: 180
  start-page: 1067
  year: 2020
  ident: ref_47
  article-title: Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.035
  contributor:
    fullname: Duscha
– volume: 4
  start-page: 188
  year: 2015
  ident: ref_14
  article-title: Impact of Propionic Acid on Liver Damage in Rats
  publication-title: Int. J. Mol. Cell. Med.
  contributor:
    fullname: Daihan
– volume: 219
  start-page: 979
  year: 1983
  ident: ref_17
  article-title: Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
  publication-title: Science
  doi: 10.1126/science.6823561
  contributor:
    fullname: Langston
– volume: 189
  start-page: 1
  year: 2018
  ident: ref_24
  article-title: ROCK inhibition in models of neurodegeneration and its potential for clinical translation
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2018.03.008
  contributor:
    fullname: Koch
– volume: 60
  start-page: 197
  year: 2006
  ident: ref_20
  article-title: Pesticide exposure and risk for Parkinson’s disease
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20904
  contributor:
    fullname: Ascherio
– volume: 40
  start-page: 1162
  year: 2019
  ident: ref_46
  article-title: Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1359-19.2019
  contributor:
    fullname: Sadler
– volume: 40
  start-page: 235
  year: 2006
  ident: ref_12
  article-title: Colonic Health: Fermentation and Short Chain Fatty Acids
  publication-title: J. Clin. Gastroenterol.
  doi: 10.1097/00004836-200603000-00015
  contributor:
    fullname: Wong
– ident: ref_36
  doi: 10.1371/journal.pone.0103740
– volume: 233
  start-page: 163
  year: 2015
  ident: ref_19
  article-title: The molecular mechanism of rotenone-induced α-synuclein aggregation: Emphasizing the role of the calcium/GSK3β pathway
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2014.11.029
  contributor:
    fullname: Yuan
– volume: 274
  start-page: 4788
  year: 2007
  ident: ref_32
  article-title: Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding
  publication-title: FEBS J.
  doi: 10.1111/j.1742-4658.2007.06004.x
  contributor:
    fullname: Srivastava
– volume: 33
  start-page: 599
  year: 2007
  ident: ref_8
  article-title: Parkinson’s disease: A dual-hit hypothesis
  publication-title: Neuropathol. Appl. Neurobiol.
  doi: 10.1111/j.1365-2990.2007.00874.x
  contributor:
    fullname: Hawkes
– volume: 5
  start-page: 699
  year: 2015
  ident: ref_40
  article-title: The Synaptic Function of α-Synuclein
  publication-title: J. Park. Dis.
– volume: 15
  start-page: 14
  year: 2008
  ident: ref_3
  article-title: Non-motor symptoms in Parkinson’s disease
  publication-title: Eur. J. Neurol.
  doi: 10.1111/j.1468-1331.2008.02056.x
  contributor:
    fullname: Poewe
– volume: 386
  start-page: 896
  year: 2015
  ident: ref_5
  article-title: Parkinson’s disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61393-3
  contributor:
    fullname: Kalia
– ident: ref_48
  doi: 10.1038/s41582-020-0344-4
– volume: 31
  start-page: 1114
  year: 2016
  ident: ref_4
  article-title: Neuropathological basis of nonmotor manifestations of Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26605
  contributor:
    fullname: Adler
– volume: 11
  start-page: 25
  year: 2020
  ident: ref_22
  article-title: The Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication
  publication-title: Front. Endocrinol.
  doi: 10.3389/fendo.2020.00025
  contributor:
    fullname: Silva
– volume: 26
  start-page: 7502
  year: 2006
  ident: ref_37
  article-title: Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0096-06.2006
  contributor:
    fullname: Leng
– volume: 95
  start-page: 75
  year: 2016
  ident: ref_43
  article-title: Fatty acids and their therapeutic potential in neurological disorders
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2016.02.014
  contributor:
    fullname: Lei
– volume: 16
  start-page: 695
  year: 2002
  ident: ref_45
  article-title: Pharmacological and Therapeutic Properties of Valproate
  publication-title: CNS Drugs
  doi: 10.2165/00023210-200216100-00004
  contributor:
    fullname: Perucca
– ident: ref_33
  doi: 10.1371/journal.pone.0162696
– volume: 11
  start-page: 625
  year: 2015
  ident: ref_2
  article-title: Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/nrneurol.2015.197
  contributor:
    fullname: Klingelhoefer
– volume: 121
  start-page: 26
  year: 2018
  ident: ref_34
  article-title: Docosahexaenoic acid protection in a rotenone induced Parkinson’s model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2018.10.015
  contributor:
    fullname: Trujillo
– volume: 22
  start-page: 8797
  year: 2002
  ident: ref_39
  article-title: Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-20-08797.2002
  contributor:
    fullname: Cabin
– volume: 17
  start-page: 169
  year: 2008
  ident: ref_44
  article-title: Histone deacetylase inhibitors: Possible implications for neurodegenerative disorders
  publication-title: Expert Opin. Investig. Drugs
  doi: 10.1517/13543784.17.2.169
  contributor:
    fullname: Hahnen
– volume: 10
  start-page: a033118
  year: 2017
  ident: ref_1
  article-title: Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a033118
  contributor:
    fullname: Erkkinen
– ident: ref_52
  doi: 10.1002/mds.28016
– volume: 30
  start-page: 350
  year: 2014
  ident: ref_7
  article-title: Gut microbiota are related to Parkinson’s disease and clinical phenotype
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26069
  contributor:
    fullname: Scheperjans
– volume: 54
  start-page: 7762
  year: 2016
  ident: ref_49
  article-title: Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson’s Disease
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-016-0249-9
  contributor:
    fullname: Liu
– volume: 24
  start-page: 197
  year: 2003
  ident: ref_6
  article-title: Staging of brain pathology related to sporadic Parkinson’s disease
  publication-title: Neurobiol. Aging
  doi: 10.1016/S0197-4580(02)00065-9
  contributor:
    fullname: Braak
SSID ssj0021415
Score 2.4803512
Snippet Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and...
Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and...
SourceID doaj
pubmedcentral
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2502
SubjectTerms 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - therapeutic use
Animals
Blotting, Western
Cell Survival - drug effects
Cells, Cultured
Dopaminergic Neurons - drug effects
Dopaminergic Neurons - metabolism
Female
Immunohistochemistry
neurodegeneration
Neuroprotective Agents - pharmacology
Neuroprotective Agents - therapeutic use
Parkinson Disease - drug therapy
Parkinson Disease - metabolism
Parkinson’s disease
Pregnancy
Propionates - pharmacology
Propionates - therapeutic use
Rats
Rats, Sprague-Dawley
rho kinase
rho-Associated Kinases - metabolism
rotenone
Rotenone - toxicity
short chain fatty acids
Tyrosine 3-Monooxygenase - metabolism
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JbtRAEG1FuYRLRAKEIRDVgROSlW73YvcxhIwCEghFE5Sb1StYCnY0dqQc8xv8Xr6EansmGotDLly9lqrseu_1UkXIex8x5zH8kZAcoEDJg8-MDDbjkkaJhCRSk2Z0v35T55fiy5W82mj1ldaEjeWBR8cdBxVyXVjnHA0i6FD6iKDGXGIOQhduyL5Ur8XUSmoxxKVxDpOjqD_-PbaaDV0i1Aj6-QSFhmL9Gwg0XR25ATfz52R3xRPhZLRvj2yFZp_snK7bs70g7fdle5MGUx2cuNqDaTzMTXfr62swHSzWC8jB_ETx3_Vw0SI9bpsAi_audki-oW7wLvjcwI-6X7aQ2qJdQxsh7YQeNoU93P_p4NM4hfOSXM7PFqfn2ap7QuaEkn1qHceMLQzTgWPK015FJYylUVFNnTBlob23ouRK6qh1HhD5mdImlby33jP-imwnq14TUIXXsTQ8GpULJ6jlTrFglYwsV9HIGfmw9mZ1MxbJqFBcJNdX_7h-Rj4mfz9emOpbDwcw6tUq6tVTUZ-RgzFIj49BYlgmcjsjxSR8k_dMzzT1r6GedsFRBTP-5n8Ydkie5UmRU5nl5Vuy3S9vwzukLb09Gr7Qv7yc72A
  priority: 102
  providerName: Directory of Open Access Journals
Title Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/32481507
https://pubmed.ncbi.nlm.nih.gov/PMC7321113
https://doaj.org/article/e6e297bccc0e4e9e8df7821c8352497c
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BPdBLRaG0W-jKh56QwsZJ7MRH2LKiSKAVWipukT9ppN1ktbtIPfZv8Pf4JYzzgYh66zWJE8cz8bwXj-cBfDcO5zyKHxKCAyQokTWBZFYFMQsdQ0DiQulXdK9v-OVdcnXP7reAdXth6qR9rYrTcr44LYvfdW7lcqFHXZ7YaHo9TuPIK6SPtmEbHbSj6C3LohiSmuXLGPn8aNGozNq1x9IY7718DYKIzAOhXiyqS_a_iUP9HMk3QWeyBx9atEjOml59hC1b7sPuuBNpO4BquqqW_peqJme6MESWhkzk-tEUcyLXZNalkRP5IAtEguS2QpBclZbMqj-FRghOihJbkZ8l-VVsVhXx4mhzUjni90PXW8Oe_z6tyY9mIecT3E0uZuPLoNVQCHTC2cYLyFGpUkmFjXHiE4Y7nkgVOh6KUCcyS4UxKslizoQTIrIY_ykX0he-V8bQ-BB2fK--AOGpES6TsZM8SnQSqlhzahVnjkbcSTaAk24082VTKiNHiuGtkP9jhQGc-_F-vdBXua4PVKuHvLV1brmNRKq01qFNrLCZcQhoqPaoEV9MD-BzY6TX23SWHUDaM1_vOf0z6GR1Ve3Wqb7-d8sjeB95Mh6yIMqOYWezerTfELFs1BDenV_cTG-HNeMf1v76AkLo8Zw
link.rule.ids 230,315,730,783,787,867,888,2109,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qZVE2UF5laAEvWCFlJi878bIMjKbQqSo0rbqL_CwRM8loJiMhVvwGv9cv4TqPqoEVbOM4sXNs33Pj63sA3mqLa16AEwnJATooodGeoEZ6EfUtRUJifeF2dGdnbHoRf7qiVztAu7MwddC-kvmwWCyHRf61jq1cLdWoixMbnc_GSRQ6hfTRPbiP89WPOye99bMCNErNBmaEHv1o2ejMmo1j02jxnYAN0ojUUaGeNaqT9t-xRP0oyTtmZ_IILrsGN9Em34bbSg7Vjz9yOf5zj_bhYUtEyXFT_Bh2TPEE9sad_ttTKM_X5cr9rVXkWOWaiEKTidhsdb4gYkPmXYQ6EdciR5JJvpTIv8vCkHn5PVfI7kleYC1yUpDLvFqXxOmuLUhpiTtqXZ86u_n5a0M-NHtEz-Bi8nE-nnqtPIOnYkYrp00XCJmIgJsI11SumWWxkL5lPvdVLNKEay3jNGKUW85Dg9QiYFy4nPpS6yB6DruuVS-AsERzm4rIChbGKvZlpFhgJKM2CJkVdADvOpiyVZOFI0PvxcGb_QXvAN47IG9vdAm06wvl-jprP3pmmAl5IpVSvokNN6m2yJUC5QgpdkwN4KBB__Yx3ZAZQNIbF7339EsQ7Tphd4vuy_-u-Qb2pvPZaXZ6cvb5EB6Ezuf3qRemR7BbrbfmFRKjSr6up8FvlsURBA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSMCFN3R5-sAJKRs7iZ34WLasWqDVCm1RxSXys0TdTVa7WQlx4m_w9_gljPOoNnDrNbETOzP2fJMZz4fQW-Ngz6OwkAAcgIMSWRNIZlUQM-IYABJHpI_onpzyo7Pk4zk736H6apL2tSrG5WI5LovvTW7laqnDPk8snJ1M0jjyDOnhyrjwJroFa5bw3lHvfC0KhqkNYsbg1YfLlmvWbjyiBqvvSWwASmQeDg0sUlO4f8caDTMld0zP9D761g-6zTi5HG9rNdY__6nneK1ZPUD3OkCKD9omD9ENWz5CdyY9D9xjVM3W1cr_tdX4QBcGy9LgqdxsTbHAcoPnfaY6lheyALCJv1SAw6vS4nn1o9CA8nFRQi98XOKvRb2usOdfW-DKYX_kujl99ufX7w0-bGNFT9DZ9MN8chR0NA2BTjirPUcdlSqVVNgY9lZhuOOJVMRxIohOZJYKY1SSxZwJJ0RkAWJQLqSvra-MofFTtOdHtY8wT41wmYyd5FGiE6JizalVnDkacSfZCL3rRZWv2mocOXgxXsT5fyIeofdemFcNfSHt5kK1vsi7D59bbiORKq01sYkVNjMOMBPVHpjCxPQIPWs14OoxvdqMUDrQjcF7hndA4k3h7k7Cz6_d8w26PTuc5p-PTz-9QHcj7_oTFkTZS7RXr7f2FeCjWr1uVsJfDNQThA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Propionic+Acid+and+Fasudil+as+Treatment+against+Rotenone+Toxicity+in+an+In+Vitro+Model+of+Parkinson%E2%80%99s+Disease&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Ostendorf%2C+Friederike&rft.au=Metzdorf%2C+Judith&rft.au=Gold%2C+Ralf&rft.au=Haghikia%2C+Aiden&rft.date=2020-05-28&rft.pub=MDPI&rft.eissn=1420-3049&rft.volume=25&rft.issue=11&rft_id=info:doi/10.3390%2Fmolecules25112502&rft_id=info%3Apmid%2F32481507&rft.externalDBID=PMC7321113
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon